Table 2. Findings of the review articles studied.

TB: Tuberculosis; DM: Diabetes mellitus; T2D: Type 2 diabetes; UTI: Urinary tract infection; CVD: Cardiovascular disease

Study Title and Authors	Year	Key Findings/Recommendations
Ottmani SE, et al. [1]	2010	Meeting summary and recommendations on TB and DM.
Ronacher K, et al. [2]	2015	Focus on acquired immunodeficiencies related to TB, including HIV/AIDS and DM.
Jeon CY, Murray MB [3]	2008	Diabetes increases the risk of active TB based on a systematic review of observational studies.
Magliano DJ, Boyko EJ [4]	2021	Provides data on global diabetes prevalence and trends from the IDF Diabetes Atlas.
Hu F [7]	2011	Discusses the role of diet, lifestyle, and genetic factors in the globalization of diabetes.
Reed GW, et al. [8]	2013	Investigates the impact of diabetes and smoking on mortality in TB patients.
Kuo MC, Lin SH, et al. [9]	2013	Reveals that T2D is an independent risk factor for TB, based on a nationwide study.
Martínez-Castelao A, et al. [10]	2015	Discusses changes in the concept and epidemiology of diabetic nephropathy.
Earle K, et al. [11]	1992	Explores familial clustering of CVD in insulin-dependent diabetes patients with nephropathy.
Tuomilehto J [12]	1998	Examines the incidence of CVD in type 1 diabetic subjects with and without diabetic nephropathy.
Ogurtsova K, da Rocha Fernandes JD [13]	2017	Provides global estimates for diabetes prevalence in 2015 and projections for 2040 from the IDF Diabetes Atlas.
Mills KT, Bundy JD, Kelly TN [14]	2016	Analyzes global disparities in hypertension prevalence and control based on population-based studies from 90 countries.
Mitchell BD, Stern MP, et al. [16]	1990	Identifies risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites.
Brownlee M [17]	2005	Discusses the pathobiology of diabetic complications and a unifying mechanism.
Zhang Y, Sun X, Icli B, et al. [18]	2017	Highlights the emerging roles of microRNAs in diabetic microvascular disease and their potential as therapeutic targets.
American Diabetes Association [19]	2010	Provides criteria for the diagnosis and classification of DM.
Khan MAB, Hashim MJ, et al. [20]	2020	Describes the epidemiology of T2D and global burden based on the Global Burden of Disease data.
Alemu M, Belete MA, et al. [21]	2020	Investigates bacterial profiles and associated factors of UTIs in diabetes patients.
Shah BR, Hux JE [23]	2003	Quantifies the risk of infectious diseases for people with diabetes.
Nath T, Das SK, Hazra S [24]	2021	Studies the pattern of uropathogens and antibiotic sensitivity in diabetes patients with UTIs.
Lim JH, Cho JH, et al. [26]	2013	Examines risk factors for recurrent UTIs in kidney transplant recipients.
Hooton TM [27]	1990	Discusses the epidemiology of UTI and the concept of significant bacteriuria.
Wukich DK, Raspovic KM, et al. [28]	2018	Indicates that patients with diabetic foot disease fear major lower-extremity amputation more than death.
Eren MA, Güneş AE, et al. [29]	2020	Examines the role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in predicting the length and cost of hospital stay in patients with infected diabetic foot ulcers.
Lature LH, Lature ML, et al. [30]	2020	Assesses UTIs among type 2 diabetic patients in a rural teaching hospital.
Kumar R, Kumar R, et al. [31]	2019	Provides the clinical and microbiological profile of UTIs in diabetic versus non-diabetic individuals.
Tiwari S, Pratyush DD, et al. [33]	2011	Discusses the risk of sepsis in diabetes and its implications.
Frydrych LM, Fattahi F, et al. [34]	2017	Explores the relationship between diabetes and sepsis, including risk, recurrence, and outcomes.